Eriochem SA is a multi-Latin company located in Colonia Avellaneda, Entre Ríos, Argentina. They specialize in the manufacturing of high-quality oncology generics and generics with value-added technology. With an efficient research and development department dedicated to nanotechnology, as well as three teams focused on the development of various products, including programmed release products, difficult to make generics, and supergenerics, Eriochem is committed to innovation and continuous improvement.

Their pursuit of international quality standards and their reliability and speed in project management have led to numerous strategic partnerships with pharmaceutical companies worldwide. Their patented processes are approved in demanding countries, demonstrating their competitiveness and innovative capabilities. With a global market approach, Eriochem produces oncology medications for Latin America, Asia Pacific, Europe, and North America, including the United States.

Their goal is to provide doctors and patients with the best treatment options at competitive prices, ensuring access to high-quality and effective medications